# A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome

> **NCT03162783** · PHASE2 · COMPLETED · sponsor: **Aldeyra Therapeutics, Inc.** · enrollment: 51 (actual)

## Conditions studied

- Dry Eye Syndromes

## Interventions

- **DRUG:** ADX-102 Ophthalmic Solution (0.5%)
- **DRUG:** ADX-102 Ophthalmic Solution (0.1%)
- **DRUG:** ADX-102 Ophthalmic Lipid Solution (0.5%)

## Key facts

- **NCT ID:** NCT03162783
- **Lead sponsor:** Aldeyra Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-15
- **Primary completion:** 2017-07-06
- **Final completion:** 2017-07-06
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2025-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03162783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03162783, "A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03162783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*